Mid April, we were quoted a potential time frame of within 3months for FDA feedback on the trial design and dose selection.
Further, my guess is they have enough dough in the bank to see out CY 2024 given we weren’t hit by a mac truck last quarterly report (if you recall I was nervous about this without the fda submission occuring on time).
My guess is also, on the back of a positive response from the FDA, Paul, Beverley, SW and Matt will have the content to formalise funding arrangements. Why? Because our dose of 2mg has been studied in 2x phase 2b trials, we have proven ourselves to conduct a phase 3 trial (stage1)and the team will have the data to point to for the metrics of the phase 3 (n of subjects, how it is monitored) and the cost will be known, as will the outcome (within a a level of probability to obtain funds; deal, debt, cap raise or combination of those).
Then the market can get back to being excited again, like we all were from 005.
These are my ramblings. Would be happy to step aside and hear the opposite thesis but that is not worth pondering is it?
DYOR
- Forums
- ASX - By Stock
- PAR
- Ann: Application for quotation of securities - PAR
Ann: Application for quotation of securities - PAR, page-13
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.5¢ |
Change
0.005(2.27%) |
Mkt cap ! $79.57M |
Open | High | Low | Value | Volume |
22.5¢ | 23.5¢ | 22.5¢ | $41.52K | 183.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 63715 | 22.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
23.0¢ | 125080 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 63715 | 0.225 |
13 | 99485 | 0.220 |
7 | 98958 | 0.215 |
5 | 131050 | 0.210 |
4 | 104982 | 0.205 |
Price($) | Vol. | No. |
---|---|---|
0.230 | 125080 | 2 |
0.235 | 139523 | 8 |
0.240 | 40833 | 1 |
0.250 | 15000 | 1 |
0.255 | 9785 | 1 |
Last trade - 14.49pm 15/08/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online